Cyclotek Announces Launch of Second Cyclotron Manufacturing Facility in Queensland, Further Expanding Access to Critical PET Radiopharmaceuticals

QUEENSLAND, AUSTRALIA: In a continued commitment to driving growth and innovation in the radiopharmaceutical industry, Cyclotek today announced the development of its second manufacturing facility in Queensland. This expansion underscores Cyclotek’s dedication to our customers and their patients, reinforcing the company’s role as a progressive and reliable partner in the industry. Cyclotek’s state-of-the-art facility will […]

Women in Nuclear: a conversation with Eden Carnegie on Quality Assurance

Cyclotek’s Media Associate Nicoletta Snellen recently sat down with Eden Carnegie, Quality Assurance Associate at Cyclotek, to talk about her professional journey in nuclear medicine. Cyclotek recently announced a partnership with Women in Nuclear Australia, with the aim to promote education, awareness and gender diversity within the nuclear industry.   Can you tell us a little bit about […]

Cyclotek acquires the business of Pettech Solutions Pty Ltd

                                            Media Release : 7 January 2019 The Cyclotek group are pleased to announce the completion of their purchase of the PETTECH Solutions FDG business. The new entity, Cyclotek NSW Pty Ltd is a […]

Advancing Molecular Imaging in NSW

Media Release 19 September 2017 Cyclotek, Cyclopharm, PETTECH Solutions and Macquarie University have today announced that they have entered into a term sheet to create a new opportunity for NSW and the broader Australian molecular imaging sector. The new entity, Cyclotek NSW Pty Ltd (a wholly owned subsidiary of Cyclotek (Aust) Pty Ltd), with support […]